Replies to post #27692 on Marker Therapeutics Inc (MRKR)

[girlfriend]

Now up in pre-market still very light volume:


Marker Therapeutics Inc (MRKR:NASDAQ)
Export chart+ WATCHLIST
Real Time Quote | Last NASDAQ LS, VOL From CTA | USD
Extended Hours | 8:13:50 AM EDT
Volume
6.50 + 0.17 (+2.69%)
12,872
Close | 07/19/2019 Volume 52 week range
6.33 -2.37 (-27.24%)
3,379,811
4.18 - 10.60

[ClosetInvestor]

“As with you, I hope for great news abd share price increase... beyond $9.00.”

This is very unlikely to happen. The run-up to $9 was planned out by those who regularly trade biotech stocks. They knew investors would get excited about prelim data regarding pancreatic cancer, pumped it to $9 and then sold before the news.

The data isn’t bad, but it’s limited and early in the clinical phase process.